David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares
REE Automotive warrant exchange offer
A total of approximately 13,065,941 warrants were exchanged for shares
Gamida Cell $20 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
Medtronic Global Holdings €3.5 billion notes offering
The investment-grade notes were issued in four tranches
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market